Archives

Green fluorescent cells on a black background.

Interim Report 1 2023/24

During this past summer quarter, we made it our most prosperous Q1 quarter to date, characterized by sustained growth.
Green, fluorescent cells on a black background.

Fluorescence Capture Protocol

The Fluorescence Capture allows HoloMonitor M4FL to capture fluorescent images for further analysis in other HoloMonitor App Suite assays. Requires App Suite 4.0 or higher.

Notice that Interim Report 1 2023/24 will be published on September 20, 2023

Phase Holographic Imaging announces that the date for publication of Interim Report 1 2023/24 is September 20, 2023.

PHI AB annual general meeting moved to 27 October 2023

The PHI AB board has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023.
Businesspeople brainstorming together with sticky notes in an of

BioStock: PHI links up with two regenerative medicine networks

BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.
ARM-ATMP-banner-web

PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership

PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
BioPhotonics-article-QPI-regenerative-medicine-cover

BioPhotonics article on how QPI advances Regenerative Medicine (Issue 07/08 2023)

The BioPhotonics July/August 2023 issue holds a feature article by PHI highlighting how HoloMonitor’s quantitative phase imaging (QPI) technology has the potential to propel regenerative medicine forward.
BioStock: PHI charts a bold course to impact regenerative medicine

BioStock: PHI charts a bold course to impact regenerative medicine

BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
righst issue of units 2022 banner

BioStock: The five best life science stocks of the first half-year

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
Three purple A549 cells on bright yellow background. They all originate from one single mother cell.

Applied Sciences Special Issue: Novel Approaches of Digital Holographic Microscopy in Cell Biology

PHI CSO Kersti Alm invites you to join this Applied Sciences Special Issue highlighting Digital Holographic Microscopy in Cell Biology.
191011121338